MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 2 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,211,000 | +16.0% | 321,076 | +44.2% | 0.00% | 0.0% |
| Q2 2023 | $2,768,000 | +1124.8% | 222,675 | +1280.7% | 0.00% | – |
| Q1 2023 | $226,000 | -27.8% | 16,128 | -26.2% | 0.00% | – |
| Q4 2022 | $313,000 | +88.6% | 21,852 | +235.3% | 0.00% | – |
| Q3 2022 | $166,000 | -88.0% | 6,518 | -86.6% | 0.00% | – |
| Q2 2022 | $1,385,000 | -25.0% | 48,751 | -6.8% | 0.00% | – |
| Q1 2022 | $1,846,000 | -55.9% | 52,326 | -47.7% | 0.00% | -100.0% |
| Q4 2021 | $4,190,000 | +3.2% | 100,008 | +20.9% | 0.00% | 0.0% |
| Q3 2021 | $4,059,000 | +383.2% | 82,722 | +310.4% | 0.00% | – |
| Q2 2021 | $840,000 | +1948.8% | 20,155 | +1645.0% | 0.00% | – |
| Q1 2021 | $41,000 | +720.0% | 1,155 | +545.3% | 0.00% | – |
| Q4 2020 | $5,000 | – | 179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $908,435,000 | 27.70% |
| Pavadi Capital LLC | 145,610 | $6,101,000 | 4.63% |
| Select Equity Group, L.P. | 20,542,503 | $860,731,000 | 2.35% |
| Beck Bode, LLC | 165,937 | $6,953,000 | 1.74% |
| Ownership Capital B.V. | 3,455,256 | $144,775,000 | 1.57% |
| Parkman Healthcare Partners LLC | 98,688 | $4,135,000 | 0.91% |
| MORGENS WATERFALL VINTIADIS & CO INC | 38,000 | $1,592,000 | 0.86% |
| STONE RUN CAPITAL, LLC | 58,785 | $2,474,000 | 0.80% |
| SECTORAL ASSET MANAGEMENT INC | 110,000 | $4,609,000 | 0.69% |
| Connacht Asset Management LP | 16,551 | $693,000 | 0.68% |